Role of 5-ASA in IBD Therapy

Role of 5-ASA in IBD Therapy

Saved in:

Bibliographic Details
Main Author:	CN Williams
Format:	Article
Language:	English
Published:	Wiley 1994-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/1994/567259
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overview of 5-ASA in Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1994-01-01)

Gut Toxicity of 5-ASA?
by: Desmond J Leddin, et al.
Published: (1993-01-01)

5-ASA Suppositories in Hemorrhoidal Disease
by: P Gionchetti, et al.
Published: (1992-01-01)

Therapy of Inflammatory Bowel Disease using New 5-ASA Compounds: An Introduction
by: Ulrich Klotz
Published: (1989-01-01)

Safety Profile of the New 5-ASA Based Compounds
by: Vinod K Sharma
Published: (1990-01-01)

Factors Predicting the Adherence to the Therapy of Italian IBD Patients
by: Cristina Bucci, et al.
Published: (2017-01-01)

Exacerbation of Ulcerative Colitis following Administration of 5-ASA Enemas
by: Barbara A. Young, et al.
Published: (1989-01-01)

Hepatic Encephalopathy Therapy in the ’90s
by: CN Williams
Published: (1994-01-01)

IBD: Progress in Pathogenesis
by: Claudio Fiocchi, et al.
Published: (1993-01-01)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
by: Jessica Mwinyi, et al.
Published: (2012-01-01)

Antioxidant Properties of 5-ASA: Potential Mechanism for Its Anti-Inflammatory Activity
by: T Yamada, et al.
Published: (1990-01-01)

Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme
by: Richard Gearry, et al.
Published: (2022-06-01)

Interprofessional approach to personalized medication management and therapy optimization in IBD care
by: Daniel Fleischmann, et al.
Published: (2025-01-01)

Special Issues in Nutritional Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1993-01-01)

Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal
by: Anita Annaházi, et al.
Published: (2015-01-01)

Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review
by: C.N. Williams
Published: (1987-01-01)

Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®
by: Jan de Laffolie, et al.
Published: (2017-01-01)

The North American Ants Described by Asa Fitch
by: William Morton Wheeler
Published: (1917-01-01)

KONSEP KEPEMIMPINAN MENURUT SYU’BAH ASA
by: Munadzir
Published: (2017-12-01)

Collagenous Colitis: Histologic Progression, Extraintestinal Features and Lack of Response to 5-ASA - A Case Report
by: Franzjosef Schweiger
Published: (1990-01-01)

Individual-network based predictions of microbial interaction signatures for response to biological therapies in IBD patients
by: Federico Melograna, et al.
Published: (2025-01-01)

Intestinal Immune Imbalance is an Alarm in the Development of IBD
by: Chunli Hu, et al.
Published: (2023-01-01)

The Function of Necroptosis and Its Treatment Target in IBD
by: Francis Atim Akanyibah, et al.
Published: (2024-01-01)

The Pediatric Patient with IBD - “Am I special?”
by: Helen Machida
Published: (1992-01-01)

Clinical Perspectives - Biologics in IBD: What's All the Fuss?
by: Hillary Steinhart
Published: (2001-01-01)

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
by: Johan Burisch, et al.
Published: (2022-06-01)

Àgbéyẹ̀wò Àṣà Ìbéyàwó ní Kákùmọ̀ Àkókó, Ìpínlẹ̀ Òǹdó
by: Deborah Bamidele Arowosegbe
Published: (2021-12-01)

A Profile of Patients on ASA or NSAIDs Hospitalized with Gastrointestinal Perforations
by: James D Bailey, et al.
Published: (1995-01-01)

Sarcopenia in IBD patients and the role of nutritional and physical activity interventions in its management – a systematic review
by: Michalina Jurkiewicz, et al.
Published: (2025-02-01)

Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age
by: Marco Gasparetto, et al.
Published: (2013-01-01)

IBD 2009: Emerging Research Frontiers on the Path to a Cure
by: A Hillary Steinhart, et al.
Published: (2010-01-01)

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
by: Stephan Buderus, et al.
Published: (2015-01-01)

BSG 2024 IBD guidelines protocol (standard operating procedures)
by: Philip Smith, et al.
Published: (2023-02-01)

The Role of Vitamin D in the Pathomechanism of Inflammatory Bowel Disease (IBD) and its Therapeutic Implications - a literature review
by: Wiktoria Maria Tomaszewska, et al.
Published: (2025-01-01)

Recently Recognized Types of Some Homoptera Described by Dr. Asa Fitch
by: Jeffrey K. Barnes
Published: (1984-01-01)

Surveillance colonoscopy in PSC-IBD: Some answers but more questions remain
by: Nilanga Nishad, et al.
Published: (2025-01-01)

The regenerating gene (Reg) family genes in inflammatory bowel disease (IBD)
by: Shin Takasawa, et al.
Published: (2025-02-01)

Genetic Counselling and Family in IBD: 30 years' Experience at the Cleveland Clinic
by: WM Michener, et al.
Published: (1990-01-01)

Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry
by: Esther A. Torres, et al.
Published: (2012-01-01)

Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD
by: Katarzyna Neubauer, et al.
Published: (2018-01-01)